Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 1.07% | 200.80 | 1.3% | $462.93m | |
| BIIB | Biogen Inc. | 0.09% | 223.21 | 1.3% | $371.70m | |
| GILD | Gilead Sciences, Inc. | -0.09% | 63.93 | 0.9% | $362.66m | |
| CELG | Celgene Corporation | 0.76% | 100.57 | 1.3% | $359.89m | |
| ILMN | Illumina, Inc. | 1.48% | 302.58 | 3.5% | $282.38m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.81% | 300.77 | 2.6% | $210.74m | |
| EXAS | Exact Sciences Corporation | 2.19% | 92.50 | 24.1% | $193.04m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.29% | 172.41 | 1.9% | $181.51m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.92% | 99.25 | 2.0% | $176.54m | |
| A | Agilent Technologies, Inc. | 1.77% | 75.31 | 1.6% | $166.98m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.39% | 83.48 | 14.6% | $138.14m | |
| ALDR | Alder Biopharmaceuticals, Inc. | -0.05% | 18.87 | 10.2% | $125.33m | |
| BMRN | BioMarin Pharmaceutical Inc. | 1.29% | 67.36 | 4.3% | $96.05m | |
| ACAD | ACADIA Pharmaceuticals Inc. | 0.10% | 40.52 | 13.4% | $95.97m | |
| INCY | Incyte Corporation | 0.46% | 76.12 | 2.5% | $87.99m |
Company Profile
Ocugen, Inc. engages in the development and commercialization of therapies for eye diseases. Its pipeline of therapies includes OCU400, OCU410, OCU200, OCU100, and OCU300. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA.